CERENO SCIENTIFIC AB B Market Cap ($60.94 Million)
Market Cap & Net Worth: CERENO SCIENTIFIC AB B (4A1)
CERENO SCIENTIFIC AB B market cap. CERENO SCIENTIFIC AB B (F:4A1) has a market capitalization of $60.94 Million (€52.12 Million) as of November 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #20954 globally and #1892 in its home market, demonstrating a -46.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CERENO SCIENTIFIC AB B's stock price €0.17 by its total outstanding shares 311365076 (311.37 Million). Also see 4A1 cash flow conversion for how efficiently the company converts equity into cash flow.
CERENO SCIENTIFIC AB B Market Cap History (2021–2026)
CERENO SCIENTIFIC AB B market cap history from 2021 to 2026. Data shows change from $169.45 Million to $60.94 Million (-9.20% CAGR). Check CERENO SCIENTIFIC AB B stock quote for real-time trading data and today's change.
CERENO SCIENTIFIC AB B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CERENO SCIENTIFIC AB B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore CERENO SCIENTIFIC AB B (4A1) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 4A1 by Market Capitalization
Companies near CERENO SCIENTIFIC AB B in the global market cap rankings as of November 1, 2026. Also see 4A1 total asset value for a full breakdown of the balance sheet.
Key companies related to CERENO SCIENTIFIC AB B by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of CERENO SCIENTIFIC AB B (2021–2026)
Market capitalization of CERENO SCIENTIFIC AB B from 2021 to today. Between 2021 and today, CERENO SCIENTIFIC AB B's market cap moved from $169.45 Million to $ 60.94 Million, with a yearly change of -9.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €60.94 Million | -73.64% |
| 2025 | €231.15 Million | +38.53% |
| 2024 | €166.87 Million | +3.01% |
| 2023 | €161.99 Million | +154.87% |
| 2022 | €63.56 Million | -62.49% |
| 2021 | €169.45 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of CERENO SCIENTIFIC AB B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $60.94 Million USD |
| MoneyControl | $60.94 Million USD |
| MarketWatch | $60.94 Million USD |
| marketcap.company | $60.94 Million USD |
| Reuters | $60.94 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CERENO SCIENTIFIC AB B
Cereno Scientific AB (publ), a clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden. The company's lead drug candidate is CS1, a HDACi, proprietary reformulation of VPA that is in phase II clinical trial for the treatment of rare disease pulmonary arterial hypertension, as well as a histone deacetylase (HDAC) inhibitor that acts as a… Read more